Rheumatology Flashcards
How do you treat raynaud’s disease?
- first-line: calcium channel blockers e.g. nifedipine, amlodipine
- IV prostacyclin (epoprostenol) infusions: effects may last several weeks/months
- sildenafil
- SSRI (fluoxetine)
- if v bad cut nerve fibres to hand
What are the factors that suggest an underlying connective tissue disease for raynauds?
- onset after 40 years
- unilateral symptoms
- rashes
- presence of autoantibodies
- features which may suggest rheumatoid arthritis or SLE, for example arthritis or recurrent miscarriages
- digital ulcers, calcinosis
- very rarely: chilblains
How should you manage OA?
- all patients should be offered help with weight loss, given advice about local muscle strengthening exercises and general aerobic fitness
- paracetamol and topical NSAIDs are first-line analgesics. Topical NSAIDs are indicated only for OA of the knee or hand
- second-line treatment is oral NSAIDs/COX-2 inhibitors, opioids, capsaicin cream and intra-articular corticosteroids. A proton pump inhibitor should be co-prescribed with NSAIDs and COX-2 inhibitors. These drugs should be avoided if the patient takes aspirin
- non-pharmacological treatment options include supports and braces, TENS and shock absorbing insoles or shoes
- if conservative methods fail then refer for consideration of joint replacement
What levels of uric acid would you expect in the blood for gout?
uric acid > 0.45 mmol/l
Who and how do you treat osteoporosis?
- treatment is indicated following osteoporotic fragility fractures in postmenopausal women who are confirmed to have osteoporosis (a T-score of - 2.5 SD or below). In women aged 75 years or older, a DEXA scan may not be required ‘if the responsible clinician considers it to be clinically inappropriate or unfeasible’
- vitamin D and calcium supplementation should be offered to all women unless the clinician is confident they have adequate calcium intake and are vitamin D replete
- alendronate is first-line
- around 25% of patients cannot tolerate alendronate, usually due to upper gastrointestinal problems. These patients should be offered risedronate or etidronate (see treatment criteria below)
- strontium ranelate and raloxifene are recommended if patients cannot tolerate bisphosphonates (see treatment criteria below)
Give examples of bisphosphonates
Alendronate
Risedronate
Etidronate
Who gets ankylosing spondylitis?
What are the features?
- 90% are HLA-B27 positive
- males (sex ratio 3:1)
- aged 20-30 years old
- typically a young man who presents with lower back pain and stiffness of insidious onset (spares hands and feet)
- stiffness is usually worse in the morning and improves with exercise
- the patient may experience pain at night which improves on getting up
- tendon disease
- enthesitis
- plantar fascitis
- rash
- bowels
- eyes- anterior uveitis
- lose lumbar lordosis
- exaggerated kyphosis
- knee flexion
=> question mark posture
What x-ray changes do you see for ankylosing spondylitis?
- sacroilitis: subchondral erosions, sclerosis
- squaring of lumbar vertebrae
- ‘bamboo spine’ (late & uncommon) (a single central radiodense line related to ossification of supraspinous and interspinous ligaments which is called dagger sign)
- syndesmophytes: due to ossification of outer fibers of annulus fibrosus
- chest x-ray: apical fibrosis
How do you manage ankylosing spondylitis?
- encourage regular exercise such as swimming
- physiotherapy
- NSAIDs are the first-line treatment
- the disease-modifying drugs which are used to treat rheumatoid arthritis (such as sulphasalazine) are only really useful if there is peripheral joint involvement
- the 2010 EULAR guidelines suggest: ‘Anti-TNF therapy should be given to patients with persistently high disease activity despite conventional treatments’ (if 2 x NSAIDS + BASDAI >4 then use biologics)
- anti TNF
- anti IL17 secukinumab
- anti IL12/23 Ustekinumab
- research is ongoing to see whether anti-TNF therapies such as etanercept and adalimumab should be used earlier in the course of the disease
What conditions are associated with ankylosing spondylitis?
Achiles disease Aortic regurg (LVH) AV node block so conduction abnormalities Apical pulmonary fibrosis Anterior uveitis Amyloidosis
What are the features of drug induced lupus?
- arthralgia
- myalgia
- skin (e.g. malar rash) and pulmonary involvement (e.g. pleurisy) are common
- ANA positive in 100%, dsDNA negative
- anti-histone antibodies are found in 80-90%
- anti-Ro, anti-Smith positive in around 5%
What are the features of sjorgrens syndrome?
- primary (PSS) or secondary to rheumatoid arthritis or other connective tissue disorders, where it usually develops around 10 years after the initial onset
- females:males (ratio 9:1).
- increased risk of lymphoid malignancy (40-60 fold).
- dry eyes: keratoconjunctivitis sicca
- dry mouth
- vaginal dryness
- arthralgia
- Raynaud’s, myalgia
- sensory polyneuropathy
- recurrent episodes of parotitis
- renal tubular acidosis (usually subclinical)
What investigations would you do for sjorgrens?
- rheumatoid factor (RF) positive in nearly 100% of patients
- ANA positive in 70%
- anti-Ro (SSA) antibodies in 70% of patients with PSS
- anti-La (SSB) antibodies in 30% of patients with PSS
- Schirmer’s test: filter paper near conjunctival sac to measure tear formation
- histology: focal lymphocytic infiltration
- also: hypergammaglobulinaemia, low C4
How many different non-steroidal anti-inflammatory drugs must a patient with ankylosing spondylitis have failed to respond to before he can be started on anti-TNF alpha inhibitors, in someone with predominantly axial disease?
Anti-TNF alpha inhibitors should be used in axial ankylosing spondylitis that has failed on 2 different NSAIDS and meets criteria for active disease on 2 occasions 12 weeks apart
What auto-antibodies would you expect to be present in SLE?
- 99% are ANA positive
- 20% are rheumatoid factor positive
- anti-dsDNA: highly specific (> 99%), but less sensitive (70%)
- anti-Smith: most specific (> 99%), sensitivity (30%)
- also: anti-U1 RNP (mixed connective tissue disease), SS-A (anti-Ro) and SS-B (anti-La)
If Ro positive you can get fetal heart block so monitor in pregnancy
What monitoring would you do for SLE?
- ESR: during active disease the CRP is characteristically normal - a raised CRP may indicate underlying infection
- complement levels (C3, C4) are low during active disease (formation of complexes leads to consumption of complement)
- anti-dsDNA titres can be used for disease monitoring (but note not present in all patients)
What are the risk factors for pseudo gout?
WHALe MP
- hyperparathyroidism
- hypothyroidism
- haemochromatosis
- acromegaly
- low magnesium, low phosphate
- Wilson’s disease
What are the features of pseudo gout? And how do you manage it?
Features
- knee, wrist and shoulders most commonly affected
- joint aspiration: weakly-positively birefringent rhomboid shaped crystals
- x-ray: chondrocalcinosis
Management
- aspiration of joint fluid, to exclude septic arthritis
- NSAIDs or intra-articular, intra-muscular or oral steroids as for gout
What are the features of reactive arthritis?
- typically develops within 4 weeks of initial infection - symptoms generally last around 4-6 months
- arthritis is typically an asymmetrical oligoarthritis of lower limbs
- dactylitis
- symptoms of urethritis
- eye: conjunctivitis (seen in 10-30%), anterior uveitis
- skin: circinate balanitis (painless vesicles on the coronal margin of the prepuce), keratoderma blenorrhagica (waxy yellow/brown papules on palms and soles)
What are the features of OA on x-ray?
- decrease of joint space
- subchondral sclerosis
- subchondral cysts
- osteophytes forming at joint margins
What’s the first line treatment for RA?
DMARD monotherapy +/- a short-course of bridging prednisolone
Monitoring of FBC & LFTs is essential due to the risk of myelosuppression and liver cirrhosis. Other important side-effects include pneumonitis
What are the features of antiphospholipid syndrome?
- venous/arterial thrombosis
- recurrent fetal loss
- livedo reticularis
- thrombocytopenia
- prolonged APTT
- other features: pre-eclampsia, pulmonary hypertension
What’s the diagnosis?
dactylitis and a first- degree relative with psoriasis, DIP affected, nail changes
Psoriatic arthritis
What can cause dactylitis?
- spondyloarthritis: e.g. Psoriatic and reactive arthritis
- sickle-cell disease
- other rare causes include tuberculosis, sarcoidosis and syphilis
Which antibody is associated with limited cutaneous systemic sclerosis?
Anti-centromere
Which antibody is associated with diffuse systemic sclerosis?
Anti-Scl-70
What are the features of dermato/myositis?
Overview
- symmetrical, proximal muscle weakness and characteristic skin lesions
- polymyositis is a variant of the disease where skin manifestations are not prominent
- may be idiopathic or associated with connective tissue disorders or underlying malignancy (typically ovarian, breast and lung cancer, found in 20-25% - more if patient older)
Skin features
- photosensitive
- macular rash over back and shoulder (shawl sign)
- heliotrope rash in the periorbital region
- mechanics’ hands
- Gottron’s papules - roughened red papules over extensor surfaces of fingers, elbows, knees
- nail fold capillary dilatation
Other features
- myalgia of proximal muscles +/- arthralgia
- dysphagia
- dysphonia
- resp muscle weakness
- interstitial lung disease: e.g. Fibrosing alveolitis or organising pneumonia
- myocarditis
- arrhythmias
- CK in 1000s!
- Raynaud’s
What antibodies are seen in dermatomyositis?
- most are ANA +ve
- 25% are anti-Mi2 +ve
- anti-Jo1 +ve
How do you treat Paget’s disease?
bisphosphonate (either oral risedronate or IV zoledronate)
What are the poor prognostic factors for RA?
- rheumatoid factor positive
- anti-CCP antibodies
- insidious onset
- systemic features
- extra articular features e.g. nodules
- poor functional status at presentation
- HLA DR4
- X-ray: early erosions (e.g. after < 2 years)
- persistent disease > 12 months
What investigations and treatment would you give for polymyalgia rheumatica?
Investigations
- ESR > 40 mm/hr
- note CK and EMG normal
- reduced CD8+ T cells
Treatment
- prednisolone e.g. 15mg/od - dramatic response
If an older patient presents with dermatomyositis what should you rule out?
ovarian, breast and lung tumours (paraneoplastic disease)
If bisphosphonates are given for a fragility fracture, when can you stop them?
At 5 years if:
- patient is < 75-years-old
- femoral neck T-score of > -2.5
- low risk according to FRAX/NOGG